Coronary Artery Plaque Burden in Asymptomatic Danish Men Aged 65-75 Years and the Relation to Glycemic Status.
Launched by SVENDBORG HOSPITAL · Aug 20, 2020
Trial Information
Current as of August 29, 2025
Completed
Keywords
ClinConnect Summary
Background
Cardiovascular disease: Cardiovascular disease (CVD) is still one of the leading causes of death in the Western Society. Despite extensive research, risk estimation based on traditional risk factors predicts risk in the general population but may not give an adequate individual risk, and can thereby under- or overestimate the risk of future cardiovascular event and therefore lead to either over- or undertreatment of a not ignorable part of the population.
T2DM/dysglycemia and atherosclerosis: The prevalence of type 2 diabetes mellitus (T2DM) is rising rapidly. Furthermore, one ...
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • 65-75 years
- • Capable of giving written informed consent
- • Participates in the DANCAVAS study
- Exclusion Criteria:
- • Body mass index (BMI) \>35
- • Atrial fibrillation and other tachyarrhythmia that unable CCTA analysis
- • Estimates Glomerular filtration rate (eGFR) \<45 ml/min
- • Contrast allergy
- • Untreated hyperthyroid
- • History of CAD or Apoplexia
- • Symptoms of CAD
- • Known Diabetes Mellitus
About Svendborg Hospital
Svendborg Hospital is a leading healthcare institution dedicated to advancing medical research and improving patient care through innovative clinical trials. Located in Denmark, the hospital is committed to exploring new treatments and therapies across various medical disciplines, facilitating collaboration between healthcare professionals, researchers, and patients. With a focus on ethical practices and patient safety, Svendborg Hospital aims to contribute valuable insights to the scientific community while enhancing the quality of healthcare services in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Svendborg, , Denmark
Patients applied
Trial Officials
Johanna Larsson, MD
Principal Investigator
Svendborg Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials